Edwards Lifesciences announces $500M accelerated share repurchase, initial ~5M shares

Edwards Lifesciences Corp

$500M accelerated share repurchase executed; initial delivery of ~5 million shares.
Total 2025 share repurchases exceed $800 million; $600M remains under authorization.
Funded with existing cash; final share count based on VWAP during ASR term.

item 8.01 item 9.01

Edwards Lifesciences Corp filing history →

Source: SEC EDGAR

accession 0001099800-25-000056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.